152 related articles for article (PubMed ID: 23835743)
21. Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle.
Smith IJ; Aversa Z; Alamdari N; Petkova V; Hasselgren PO
J Cell Biochem; 2010 Nov; 111(4):1059-73. PubMed ID: 20677217
[TBL] [Abstract][Full Text] [Related]
22. Heart failure increases atrogin-1 and MuRF1 gene expression in skeletal muscle with fiber type-specific atrophy.
Carvalho RF; Castan EP; Coelho CA; Lopes FS; Almeida FL; Michelin A; de Souza RW; Araújo JP; Cicogna AC; Dal Pai-Silva M
J Mol Histol; 2010 Feb; 41(1):81-7. PubMed ID: 20349269
[TBL] [Abstract][Full Text] [Related]
23. Tumor inoculation site affects the development of cancer cachexia and muscle wasting.
Matsuyama T; Ishikawa T; Okayama T; Oka K; Adachi S; Mizushima K; Kimura R; Okajima M; Sakai H; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Kokura S; Naito Y; Itoh Y
Int J Cancer; 2015 Dec; 137(11):2558-65. PubMed ID: 26016447
[TBL] [Abstract][Full Text] [Related]
24. Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo.
Pires-Oliveira M; Maragno AL; Parreiras-e-Silva LT; Chiavegatti T; Gomes MD; Godinho RO
J Appl Physiol (1985); 2010 Feb; 108(2):266-73. PubMed ID: 19926828
[TBL] [Abstract][Full Text] [Related]
25. [MAFbx and MuRF1 mRNA expression and its relationship with muscular contractility following free muscle transfer].
Liu AT; Yu DZ; Zhang YF; Zhang WJ; Ding WJ; Ren AJ; Fang CP; Jiang H
Zhonghua Zheng Xing Wai Ke Za Zhi; 2009 May; 25(3):217-21. PubMed ID: 19803207
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
27. Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice.
Allen DL; Cleary AS; Lindsay SF; Loh AS; Reed JM
J Appl Physiol (1985); 2010 Sep; 109(3):692-701. PubMed ID: 20595541
[TBL] [Abstract][Full Text] [Related]
28. Elevated expression of activins promotes muscle wasting and cachexia.
Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
[TBL] [Abstract][Full Text] [Related]
29. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.
Goodman CA; McNally RM; Hoffmann FM; Hornberger TA
Mol Endocrinol; 2013 Nov; 27(11):1946-57. PubMed ID: 24002653
[TBL] [Abstract][Full Text] [Related]
30. Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy.
Senf SM; Dodd SL; McClung JM; Judge AR
FASEB J; 2008 Nov; 22(11):3836-45. PubMed ID: 18644837
[TBL] [Abstract][Full Text] [Related]
31. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.
Granado M; Priego T; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1007-14. PubMed ID: 16030067
[TBL] [Abstract][Full Text] [Related]
32. GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1.
Yamamoto D; Ikeshita N; Matsubara T; Tasaki H; Herningtyas EH; Toda K; Iida K; Takahashi Y; Kaji H; Chihara K; Okimura Y
Life Sci; 2008 Feb; 82(9-10):460-6. PubMed ID: 18191156
[TBL] [Abstract][Full Text] [Related]
33. Myogenin regulates denervation-dependent muscle atrophy in mouse soleus muscle.
Macpherson PC; Wang X; Goldman D
J Cell Biochem; 2011 Aug; 112(8):2149-59. PubMed ID: 21465538
[TBL] [Abstract][Full Text] [Related]
34. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle.
Frost RA; Nystrom GJ; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E501-12. PubMed ID: 17003238
[TBL] [Abstract][Full Text] [Related]
35. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
[TBL] [Abstract][Full Text] [Related]
36. Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy.
Kukreti H; Amuthavalli K; Harikumar A; Sathiyamoorthy S; Feng PZ; Anantharaj R; Tan SL; Lokireddy S; Bonala S; Sriram S; McFarlane C; Kambadur R; Sharma M
J Biol Chem; 2013 Mar; 288(9):6663-78. PubMed ID: 23297411
[TBL] [Abstract][Full Text] [Related]
37. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
[TBL] [Abstract][Full Text] [Related]
38. Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis.
Krawiec BJ; Frost RA; Vary TC; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E969-80. PubMed ID: 16046454
[TBL] [Abstract][Full Text] [Related]
39. Short bouts of stretching increase myo-D, myostatin and atrogin-1 in rat soleus muscle.
Peviani SM; Gomes AR; Moreira RF; Moriscot AS; Salvini TF
Muscle Nerve; 2007 Mar; 35(3):363-70. PubMed ID: 17143883
[TBL] [Abstract][Full Text] [Related]
40. Molecular determinants of skeletal muscle mass: getting the "AKT" together.
Nader GA
Int J Biochem Cell Biol; 2005 Oct; 37(10):1985-96. PubMed ID: 16125108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
